tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Jasper Therapeutics downgraded to Market Perform from Outperform at BMO Capital
PremiumThe FlyJasper Therapeutics downgraded to Market Perform from Outperform at BMO Capital
18d ago
Hold Rating for Jasper Therapeutics Amid Uncertainties in Briquilimab’s Clinical Trials and Competitive Challenges
Premium
Ratings
Hold Rating for Jasper Therapeutics Amid Uncertainties in Briquilimab’s Clinical Trials and Competitive Challenges
18d ago
Cantor cuts Jasper Therapeutics to Neutral after briquilimab update
Premium
The Fly
Cantor cuts Jasper Therapeutics to Neutral after briquilimab update
19d ago
Buy Rating Affirmed for Jasper Therapeutics Amid Promising Efficacy and Resolved Trial Setbacks
PremiumRatingsBuy Rating Affirmed for Jasper Therapeutics Amid Promising Efficacy and Resolved Trial Setbacks
19d ago
Jasper Therapeutics price target lowered to $20 from $40 at H.C. Wainwright
Premium
The Fly
Jasper Therapeutics price target lowered to $20 from $40 at H.C. Wainwright
19d ago
Jasper Therapeutics Reports Promising Briquilimab Study Results
Premium
Company Announcements
Jasper Therapeutics Reports Promising Briquilimab Study Results
19d ago
Promising Potential of Jasper Therapeutics’ Briquilimab Drives Buy Rating
PremiumRatingsPromising Potential of Jasper Therapeutics’ Briquilimab Drives Buy Rating
1M ago
Jasper Therapeutics Reports Positive Phase 1b/2a Study Results
Premium
Company Announcements
Jasper Therapeutics Reports Positive Phase 1b/2a Study Results
1M ago
Jasper Therapeutics presents data from SPOTLIGHT Phase 1b/2a study
Premium
The Fly
Jasper Therapeutics presents data from SPOTLIGHT Phase 1b/2a study
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100